...J. Evan Sadler, MD, PhD The American Society of Hematology has always been committed to supporting basic hematology research, which is the foundation for progress in translational and clinical research. During his term as President last year, Dr. Hal Broxmeyer was instrumental in highlighting...

.... It has been a true pleasure to serve as the 2010 ASH president. Highlights of my term clearly include close interactions with the committed ASH staff, officers, and Executive and many other committee members, as well as you, the members, who are the “heart, soul, and lifeblood” of ASH. Together our goal...

...Alexis Thompson, MD, MPH As I begin my final President’s Column, I am reminded of my predecessor Dr. Kenneth Anderson’s assessment that a key part of ASH’s influence on hematology/oncology research lies in building awareness about important current and emerging topics. Throughout the course...

.... In an earlier President’s Column, I shared some of my thoughts about the National Cancer Moonshot as well as the pivotal role of precision medicine in the next wave of discovery in conquering hematologic diseases. This summer, ASH announced a collaboration with the Leukemia & Lymphoma Society (LLS...

... international activities and to welcome hematologists and scientists from outside of North America to become full members of ASH. ASH's “Global Reach” was the subject of Dr. Martin Tallman's President's Column in March/April 2021. He described ASH's many international programs and invited us to think about...

.... September is Sickle Cell Awareness Month, and in a President’s Column written earlier this year, I highlighted initiatives through which the Society can make a difference, including parts of the world where the sickle cell disease (SCD) burden is greatest. I wrote about ASH’s efforts to launch a global...

..., and I’d like to use this column – my last as ASH president – to focus on our extraordinary collaboration with the Wallace H. Coulter Foundation (WHCF) and its profound impact on our Society. The ASH-WHCF partnership began in 2003 when the WHCF provided “seed” money to launch the ASH Clinical Research...

... with members of the Executive Committee, particularly the last three presidents of the Society — Armand Keating, Jan Abkowitz, and Linda Burns. Their President’s Columns have provided readers with candid insight into the priorities and goals of the Society. I would also like to thank the staff behind...

... as I look forward to 2014 and the honor of serving as president of ASH. In this first column of the New Year, I wish to share with you the vision that I, and other leaders of ASH, have for tackling the challenges we, as hematology clinicians and researchers, continue to face. I touched...

... membership, who serve as a volunteer board of trustees for the organization. As 2019 president, I am asked to oversee the board’s meetings and shepherd the Society as we make decisions that affect our financial outlays, our membership, and our patients. My experience has been that board members share...

... offerings this year including Scientific Spotlight Sessions, Continuing Conversations (formerly “Scientific Forums”), a Special Symposium on Innovation and the Future of Hematology (mentioned in Dr. Abkowitz’s President’s Column), two Featured Topic Discussions on novel targets in hemostasis and thrombosis...

...Janis L. Abkowitz, MD It is an absolute honor to write as president of ASH, and I am especially honored to be your leader at this complex time when our challenges as hematology clinicians and researchers are huge, but when the opportunities are equally compelling. I am writing this first...

...Stephanie J. Lee, MD, MPH Many people have asked me, “How is your year as ASH president going?” They send condolences (“Sorry you have to be president this year”) or comment, “Bet you never thought it would be like this.” Nope, I never thought it would be like this. I feared all sorts...

... Registry. In the July/August issue’s President’s column, Dr. Kenneth Anderson highlighted the need to facilitate the sharing of research-grade data for ASH members and the hematology community. To that end, ASH has committed to developing its own data registry. We are excited to share with you ASH’s...

... health care that includes the right to abortion. The long-term impact on New Orleans, its hospitality industry, and convention center should we move upcoming meetings from Louisiana, was appreciated by the Governor. I recently argued in this column ( The Hematologist . 2022;19[5]:2) that lawmakers...

... leukemias, lymphoproliferative disorders, plasma cell dyscrasias, myeloproliferative neoplasms, and related transplantation biology know that their scholarly contributions are recognized and respected by the Society. This column will be my last as President of ASH. I hope that you’ve had as fulfilling...

... advocated for The Hematologist  while using the President’s Column to relay key initiatives and positions on behalf of the Society. It is with this village of support that I welcome Dr. Laura Michaelis as the sixth (and first female) Editor-in-Chief of The Hematologist  starting in January 2018. Laura...